Kluster Kepakaran/ Cluster of Expertise :
Kesihatan dan Perubatan Termaju,
Biografi/ Biography :
Dr AKM Moyeenul Huq joined the Faculty of Pharmacy, UKM in 2024. He obtained his B. Pharm. (Hons.) and MS in Pharmaceutical Technology from the Department of Pharmacy, University of Asia Pacific in the year 2007 and 2009 respectively. He is a registered Pharmacist (Grade A) under the Govt. of the People`s Republic of Bangladesh. Later he obtained his PhD from the Center for Drug and Herbal Research, Faculty of Pharmacy, Universiti Kebangsaan Malaysia (UKM) in 2018. The field of his PhD research was the Pharmacology of Natural Products. He published his research works in several reputed journals indexed in Scopus and Web of Science. He also presented his works orally in different international conferences in Malaysia, Indonesia and UK. His research interests include natural product, pharmacology of natural products, development of herbal medicine and drug discovery. He is also a member of Malaysian Association of Cancer Research (MACR) and Bangladesh Pharmaceutical Society (BPS).
umme sharmin, akm moyeenul huq, jamia azdina jamal. (2025). a review on analytical approaches for identifying citrus phytochemicals. - methods objects of chemical analysis. 159 - 172.
md shaekh forid, miah roney, a. k. m. moyeenul huq, md. nazim uddin, mohd hamzah bin mohd nasir, mohd fadhlizil fasihi mohd aluwi, muhammad saupi azuri, wan maznah wan ishak. (2025). investigation of curcumin analogs by molecular docking, md simulation and mm-pbsa calculation as potential gsk3-ß protein inhibitor to treat wounds. - letters in applied nanobioscience. 1 - 18.
miah roney, md nazim uddin, suhaila sapari, fazira ilyana abdul razak, a k m moyeenul huq, normaiza zamri, mohd fadhlizil fasihi mohd aluwi. (2025). in silico approaches to identify novel anti-diabetic type 2 agents against dipeptidyl peptidase iv from isoxazole derivatives of usnic acid. - 3 biotech. 1 - 17.
miah roney, md. nazim uddin, suhaila sapari, fazira ilyana abdul razak, a. k. m. moyeenul huq, normaiza binti zamri, mohd fadhlizil fasihi mohd aluwi. (2025). in silico approaches to identify novel anti-diabetic type 2 agents against dipeptidyl peptidase iv from isoxazole derivatives of usnic acid. - 3 biotech. 1 - 17.
miah roney, abdul rashid issahaku, a. k. m. moyeenul huq, suhaila sapari, fazira ilyana abdul razak, anke wilhelm, normaiza binti zamri, sabrina sharmin, md. rabiul islam, mohd fadhlizil fasihi mohd aluwi. (2024). correction: in silico exploration of isoxazole derivatives of usnic acid: novel therapeutic prospects against a-amylase for diabetes treatment. - cell biochemistry and biophysics. 1 - 1.
akm moyeenul huq, johnson stanslas, nisarat nizhum, miah roney, faridah abas, jamia azdina jamal. (2024). estrogenic post-menopausal anti-osteoporotic mechanism of achyranthes aspera l.: phytochemicals and network pharmacology approaches. - heliyon. 1 - 14.
miah roney, akm moyeenul huq, mohd fadhlizil fasihi mohd aluwi. (2024). record dengue deaths in bangladesh as disease patterns change. - acta tropica. 1-3.
eman elsharkawy, may alqurashi, mona alshathly, a. k. m. moyeenul huq. (2024). antiviral activity of curcuminoids derived from deverra tortuosa plant. - journal of food biochemistry. 1 - 9.
miah roney, md nazim uddin, suhaila sapari, fazira ilyana abdul razak, a k m moyeenul huq, normaiza zamri, mohd fadhlizil fasihi mohd aluwi. (2025). in silico approaches to identify novel anti-diabetic type 2 agents against dipeptidyl peptidase iv from isoxazole derivatives of usnic acid. - 3 biotech. 1 - 17.
miah roney, md. nazim uddin, suhaila sapari, fazira ilyana abdul razak, a. k. m. moyeenul huq, normaiza binti zamri, mohd fadhlizil fasihi mohd aluwi. (2025). in silico approaches to identify novel anti-diabetic type 2 agents against dipeptidyl peptidase iv from isoxazole derivatives of usnic acid. - 3 biotech. 1 - 17.
miah roney, abdul rashid issahaku, a. k. m. moyeenul huq, suhaila sapari, fazira ilyana abdul razak, anke wilhelm, normaiza binti zamri, sabrina sharmin, md. rabiul islam, mohd fadhlizil fasihi mohd aluwi. (2024). correction: in silico exploration of isoxazole derivatives of usnic acid: novel therapeutic prospects against a-amylase for diabetes treatment. - cell biochemistry and biophysics. 1 - 1.
miah roney, md. nazim uddin, suhaila sapari, fazira ilyana abdul razak, a. k. m. moyeenul huq, normaiza binti zamri, mohd fadhlizil fasihi mohd aluwi. (2025). in silico approaches to identify novel anti-diabetic type 2 agents against dipeptidyl peptidase iv from isoxazole derivatives of usnic acid. - 3 biotech. 1 - 17.
miah roney, md nazim uddin, suhaila sapari, fazira ilyana abdul razak, a k m moyeenul huq, normaiza zamri, mohd fadhlizil fasihi mohd aluwi. (2025). in silico approaches to identify novel anti-diabetic type 2 agents against dipeptidyl peptidase iv from isoxazole derivatives of usnic acid. - 3 biotech. 1 - 17.
umme sharmin, akm moyeenul huq, jamia azdina jamal. (2025). a review on analytical approaches for identifying citrus phytochemicals. - methods objects of chemical analysis. 159 - 172.
md shaekh forid, miah roney, a. k. m. moyeenul huq, md. nazim uddin, mohd hamzah bin mohd nasir, mohd fadhlizil fasihi mohd aluwi, muhammad saupi azuri, wan maznah wan ishak. (2025). investigation of curcumin analogs by molecular docking, md simulation and mm-pbsa calculation as potential gsk3-ß protein inhibitor to treat wounds. - letters in applied nanobioscience. 1 - 18.
miah roney, abdul rashid issahaku, a. k. m. moyeenul huq, suhaila sapari, fazira ilyana abdul razak, anke wilhelm, normaiza binti zamri, sabrina sharmin, md. rabiul islam, mohd fadhlizil fasihi mohd aluwi. (2024). correction: in silico exploration of isoxazole derivatives of usnic acid: novel therapeutic prospects against a-amylase for diabetes treatment. - cell biochemistry and biophysics. 1 - 1.
PHARMACY :CLINICAL AND HEALTH SCIENCES
Natural Product Pharmacology, Drug Discovery
Pengalaman / Experience : 12 tahun/years(s)